Maersk inks partnership with Novo Nordisk on global cold chain logistics
Copenhagen – A.P. Moller – Maersk has signed a logistics agreement with Novo Nordisk from 2021. The three-year agreement on cold chain logistics covers transportation including ocean services and inland logistics.
“We are proud to be chosen as one of Novo Nordisk´s main logistic companies,” saidVincent Clerc, executive vice-president and CEO ocean and logistics at A.P. Moller – Maersk. “Transporting pharmaceuticals on a global level is a demanding task with various complexities that require flexible and resilient supply chains as well as digital and eco-friendly solutions. This achievement showcases the rapid transformation of A.P. Moller – Maersk as a modern end-to-end logistics company with fully controlled assets.”
One of the largest pharmaceutical companies in the world, Novo Nordisk has chosen Maersk´s ECO Delivery to reduce the carbon footprint in transportation. The initiative uses sustainable biofuel to power selected Maersk-vessels and helps Novo Nordisk to make progress towards its ambitious sustainability goals.
“Our ambition of achieving zero environmental impact is a cornerstone of our aspiration to be a truly sustainable business,” said Rune Sylow, corporate vice-president, strategic sourcing at Novo Nordisk. “We consider A.P. Moller – Maersk to be the right global distribution partner to secure the steady, environmentally friendly delivery of our high-value shipments and we look forward to the collaboration.”